Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LSD1/KDM1A inhibitors in clinical trials: advances and prospects
Yuan Fang, Guochao Liao, Bin Yu
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 350

Showing 1-25 of 350 citing articles:

Shortening Synthetic Routes to Small Molecule Active Pharmaceutical Ingredients Employing Biocatalytic Methods
Stefan Simić, Erna Zukić, Luca Schmermund, et al.
Chemical Reviews (2021) Vol. 122, Iss. 1, pp. 1052-1126
Open Access | Times Cited: 175
Targeting epigenetic regulators to overcome drug resistance in cancers
Nan Wang, Ting Ma, Bin Yu
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 147
Recent developments in epigenetic cancer therapeutics: clinical advancement and emerging trends
Kunal Nepali, Jing‐Ping Liou
Journal of Biomedical Science (2021) Vol. 28, Iss. 1
Open Access | Times Cited: 143
Post‐translational modifications of histones: Mechanisms, biological functions, and therapeutic targets
Ruiqi Liu, Jiajun Wu, H. Henry Guo, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 104
Signaling pathways and targeted therapies in lung squamous cell carcinoma: mechanisms and clinical trials
Zhenyi Niu, Runsen Jin, Yan Zhang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 91
The role of epigenetic modifications in drug resistance and treatment of breast cancer
Mohsen Karami Fath, Ali Azargoonjahromi, Arash Kiani, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 85
KDM1A promotes thyroid cancer progression and maintains stemness through the Wnt/β-catenin signaling pathway
Wei Zhang, Xianhui Ruan, Yaoshuang Li, et al.
Theranostics (2022) Vol. 12, Iss. 4, pp. 1500-1517
Open Access | Times Cited: 72
Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies
Ailin Zhao, Hui Zhou, Jinrong Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 62
Methylation across the central dogma in health and diseases: new therapeutic strategies
Ruochen Liu, Erhu Zhao, Huijuan Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 55
Circulating tumor cells: from new biological insights to clinical practice
Xuyu Gu, Shiyou Wei, Xin Lv
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 28
Pharmacological targeting of the cancer epigenome
Nathaniel W. Mabe, Jennifer A. Perry, Clare F. Malone, et al.
Nature Cancer (2024) Vol. 5, Iss. 6, pp. 844-865
Closed Access | Times Cited: 18
Epigenetic regulation in cancer
Minzhi Gu, Bo Ren, Yuan Fang, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 17
Combination Therapy and Dual-Target Inhibitors Based on LSD1: New Emerging Tools in Cancer Therapy
Liang Shen, Bo Wang, ShaoPeng Wang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 2, pp. 922-951
Closed Access | Times Cited: 16
LSD1: more than demethylation of histone lysine residues
Bruno Perillo, Alfonso Tramontano, Antonio Pezone, et al.
Experimental & Molecular Medicine (2020) Vol. 52, Iss. 12, pp. 1936-1947
Open Access | Times Cited: 131
Histone modifications in epigenetic regulation of cancer: Perspectives and achieved progress
Маргарита Е. Неганова, С. Г. Клочков, Yulia Aleksandrova, et al.
Seminars in Cancer Biology (2020) Vol. 83, pp. 452-471
Closed Access | Times Cited: 126
Pioneer of prostate cancer: past, present and the future of FOXA1
Mona Teng, Stanley Zhou, Changmeng Cai, et al.
Protein & Cell (2020) Vol. 12, Iss. 1, pp. 29-38
Open Access | Times Cited: 121
Natural products as LSD1 inhibitors for cancer therapy
Yuan Fang, Chao Yang, Zhiqiang Yu, et al.
Acta Pharmaceutica Sinica B (2020) Vol. 11, Iss. 3, pp. 621-631
Open Access | Times Cited: 102
Tranylcypromine Based Lysine-Specific Demethylase 1 Inhibitor: Summary and Perspective
Xing‐Jie Dai, Ying Liu, Xiao-Peng Xiong, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 23, pp. 14197-14215
Closed Access | Times Cited: 75
LSD1‐Demethylated LINC01134 Confers Oxaliplatin Resistance Through SP1‐Induced p62 Transcription in HCC
Luyuan Ma, An Xu, Lei Kang, et al.
Hepatology (2021) Vol. 74, Iss. 6, pp. 3213-3234
Closed Access | Times Cited: 75
Roles of lysine-specific demethylase 1 (LSD1) in homeostasis and diseases
Dongha Kim, Keun Il Kim, Sung Hee Baek
Journal of Biomedical Science (2021) Vol. 28, Iss. 1
Open Access | Times Cited: 74
LSD1 inhibition sustains T cell invigoration with a durable response to PD-1 blockade
Yi Liu, Brian Debo, Mingfeng Li, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 70
Reversible Lysine Specific Demethylase 1 (LSD1) Inhibitors: A Promising Wrench to Impair LSD1
Xing‐Jie Dai, Ying Liu, Lei-Peng Xue, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 5, pp. 2466-2488
Closed Access | Times Cited: 68
The roles of histone modifications in tumorigenesis and associated inhibitors in cancer therapy
Yunkai Yang, Min Zhang, Yan Wang
Journal of the National Cancer Center (2022) Vol. 2, Iss. 4, pp. 277-290
Open Access | Times Cited: 59
GABA regulates IL-1β production in macrophages
Jian Fu, Ziyi Han, Zebiao Wu, et al.
Cell Reports (2022) Vol. 41, Iss. 10, pp. 111770-111770
Open Access | Times Cited: 53
Role of Lysine‐Specific Demethylase 1 in Metabolically Integrating Osteoclast Differentiation and Inflammatory Bone Resorption Through Hypoxia‐Inducible Factor 1α and E2F1
Kohei Doi, Koichi Murata, Shuji Ito, et al.
Arthritis & Rheumatology (2022) Vol. 74, Iss. 6, pp. 948-960
Open Access | Times Cited: 44
Page 1 - Next Page

Scroll to top